Showing results (1-10 of 575) with videos related to
Sort By:
Pageof 58
Hematology/Oncology Clinics of North America|April 3, 2010
Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromesDavid P Steensma, Richard M StoneLeukemia Research|January 3, 2015
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromesDaniel A Roberts, Martha Wadleigh, Anne M McDonnell, et al.British Journal of Haematology|February 26, 2016
Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromesGregory A Abel, Angel M Cronin, Oreofe O Odejide, et al.Current Hematologic Malignancy Reports|March 5, 2011
The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debateDavid P SteensmaMayo Clinic Proceedings|September 7, 2007
Exacerbation of asthma by Florida "red tide" during an ocean sailing tripDavid P SteensmaBest Practice & Research. Clinical Haematology|December 4, 2012
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?David P SteensmaBest Practice & Research. Clinical Haematology|November 21, 2017
The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromesDavid P SteensmaLeukemia Research|August 28, 2012
Historical perspectives on myelodysplastic syndromesDavid P SteensmaPageof 58